Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema (bilateral)
ICD-10 E10.3393 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema (bilateral).
E10.3393 refers to a specific condition in which a patient has Type 1 diabetes mellitus accompanied by moderate nonproliferative diabetic retinopathy (NPDR) affecting both eyes, without the presence of macular edema. Type 1 diabetes is characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Diabetic retinopathy is a common complication of diabetes, resulting from damage to the retinal blood vessels due to chronic hyperglycemia. Moderate NPDR is identified by the presence of microaneurysms, retinal hemorrhages, and exudates, but without the more severe complications associated with proliferative diabetic retinopathy or macular edema. The absence of macular edema indicates that the central vision is less likely to be affected at this stage. Regular monitoring of HbA1c levels is crucial in managing diabetes and preventing complications, with targets typically set below 7% for most adults. Insulin management is essential for maintaining glycemic control, and patients may require adjustments in their insulin regimen based on their blood glucose levels and lifestyle factors.
Detailed records of diabetes management, including insulin regimens and HbA1c levels.
Patients presenting with uncontrolled diabetes, requiring insulin adjustments.
Ensure comprehensive documentation of diabetes complications and management strategies.
Detailed eye examination findings, including retinal imaging results.
Routine eye exams for diabetic patients to monitor for retinopathy.
Accurate reporting of retinopathy severity and absence of macular edema is critical.
Used during routine eye exams for diabetic patients.
Document findings of retinopathy and any treatment recommendations.
Ophthalmologists should ensure detailed documentation of retinopathy severity.
Specifying 'bilateral' indicates that both eyes are affected by moderate NPDR, which is crucial for accurate diagnosis and treatment planning.
Patients should have their HbA1c levels checked at least twice a year, or more frequently if their levels are above target or if there are changes in their treatment plan.
